Stempoint Capital’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.15M Buy
+42,200
New +$4.1M 0.74% 43
2025
Q1
– Sell
-61,403
Closed -$7M – 63
2024
Q4
$7M Buy
+61,403
New +$7.01M 1.75% 22

Other funds holding BNTX

Stempoint Capital's BNTX Position: Q3 2026 in Review

Stempoint Capital opened a new position in BioNTech (BNTX) in Q3 2026: 42,200 shares worth $4.15M. The stake represents 0.74% of the portfolio and ranks #43 among its holdings. This is a return to the name: Stempoint Capital previously reported a position in BNTX as recently as Q4 2024.

Stempoint Capital first reported a position in BNTX in Q4 2024 and has held it in 2 quarters since. The position peaked at $7M in Q4 2024. 302 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Stempoint Capital held 42,200 shares of BioNTech worth $4.15M as of Q3 2026.
  • BioNTech was a new Stempoint Capital position in Q3 2026.
  • BioNTech made up 0.74% of Stempoint Capital's portfolio in Q3 2026, its #43 holding.
  • Stempoint Capital first reported a position in BioNTech in Q4 2024 and has held it in 2 quarters since.
  • Stempoint Capital's BioNTech position peaked at $7M in Q4 2024.
  • 302 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Stempoint Capital's 13F filing for Q3 2026, filed 16 Nov 2026.